Accretion Nutraveda Limited was originally incorporated on March 16, 2021. The Company is engaged in the manufacturing of Ayurvedic and nutraceutical products across multiple dosage forms, combining classical Ayurvedic principles with modern nutraceutical science. Accretion Nutraveda primarily operates as a contract manufacturer, catering to clients in India and export markets such as Sri Lanka, Singapore, and the United States.

Product Portfolio

Accretion Nutraveda offers a diversified range of dosage forms, including:

i) Tablets (film-coated, chewable, uncoated) for liver care, gynaecological care, bone and joint health, and respiratory support
ii) Capsules (hard gelatin and HPMC) for detoxification, women’s health, cognitive support, immunity, and wellness
iii) Oral Liquids such as syrups, suspensions, tonics, and decoctions (kadhas) suited for paediatric and geriatric use
iv) Oral Powders / Churans for digestive health and nutrition
v) Ayurvedic Oils for musculoskeletal, dermatological, and hair care applications
vi) External Preparations including balms, ointments, creams, and gels for pain relief, skin care, and hair care

Business Verticals and Revenue Model

The Company operates through two primary sales streams:

1. Domestic Sales and Merchant Exports (Loan License Basis) – the dominant revenue contributor
2. Direct Export Sales – a growing segment contributing to international expansion

In FY 2024–25, domestic and merchant exports accounted for 96.62% of revenue, while direct exports contributed 3.38%.

Key Strengths

i) Experienced promoters and management team with healthcare and nutraceutical expertise
ii) Diverse portfolio covering over 72 formulations across multiple dosage forms
iii) Strong quality assurance and regulatory compliance framework
iv) Scalable CDMO business model with domestic and export capabilities
v) Established relationships with customers and suppliers